Home Current Archive Editorial Team
About us
About Author Guidelines Aims and scope
News Contact
×
Home Current Archive Editorial board

About Author Guidelines Aims and scope
News Contact
Review paper
Published: 12.07.2020. Biochemistry
<< Prev | Next >>
PDF
https://doi.org/10.17392/1179-20

Treatment effectiveness and outcome in patients with a relapse and newly diagnosed multidrug-resistant pulmonary tuberculosis

By
Dmytro Butov Orcid logo ,
Dmytro Butov
Contact Dmytro Butov

Department of Phthisiology and Pulmonology, Kharkiv National Medical University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Valeriy Myasoedov ,
Valeriy Myasoedov

Department of Phthisiology and Pulmonology, Kharkiv National Medical University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Mykola Gumeniuk ,
Mykola Gumeniuk

Department of Technologies of Treatment of Nonspecific Lung Diseases, National Institute of Phthisiology and Pulmonology named after FG Yanovskyi NAMS of Ukraine, Kyiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Galyna Gumeniuk ,
Galyna Gumeniuk

Department of Technologies of Treatment of Nonspecific Lung Diseases, National Institute of Phthisiology and Pulmonology named after FG Yanovskyi NAMS of Ukraine, Kyiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Oleksandra Choporova ,
Oleksandra Choporova

Department of Phthisiology and Pulmonology, Kharkiv National Medical University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Anton Tkachenko ,
Anton Tkachenko

Department of Biochemistry, Kharkiv National Medical University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Oleksandra Akymenko ,
Oleksandra Akymenko

Medical Division #3, Regional Anti-TB Dispensary #1, Kharkiv, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Olena Borysova ,
Olena Borysova

Department of Phthisiology and Pulmonology, Kharkiv National Medical University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Olena Goptsii ,
Olena Goptsii

Department of Internal Medicine #1, Kharkiv National Medical University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Yevhenii Vorobiov ,
Yevhenii Vorobiov

Department of Internal Medicine, VN Karazin Kharkiv National University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar
Tetiana Butova
Tetiana Butova

Department of Internal Medicine, VN Karazin Kharkiv National University, Kharkiv, Ukraine

View authors publications

Search this author on:

PubMed | Google Scholar

Abstract

Aim
 To investigate the treatment effectiveness and outcome in patients with pulmonary tuberculosis relapse and newly diagnosed multidrug resistant pulmonary tuberculosis (MDR-TB).
Methods
 A total of 240 pulmonary MDR-TB patients, including 114 ones with tuberculosis relapse and 126 cases of newly diagnosed pulmonary tuberculosis, were examined. Effectiveness of the basic antimycobacterial therapy course was evaluated based on the time to normalization of tuberculosis clinical manifestation, sputum culture and acid-fast bacilli stain conversion, cavity closure, disappearance of infiltrative and focal changes in the pulmonary tissue. Treatment outcomes were evaluated as cured, treatment completed, treatment failed, died and lost to follow-up according to the World Health Organization guidelines.
Results
When assessing the treatment effectiveness in patients with MDR-TB, a worse clinical and chest radiograph dynamics was observed in tuberculosis relapse against the background of high parameters of treatment failure (18.4 %) and low cured (34.2 %) compared with newly diagnosed pulmonary tuberculosis (7.1% and 58.7 %, respectively) (p=0.008 and p<0.001, respectively).
Conclusion
Standard treatment effectiveness in patients with newly diagnosed MDR-TB manifested by faster improvement and stabilization of health, earlier sputum culture and smear conversion, higher frequency of cavity closure and achievement of certain clinical and radiographic improvement against the background of fewer cases of treatment failure and a higher number of cured patients compared with MDR-TB relapse.

Keywords:

Mycobacterium,
X-ray,
culture,
microscopy Methods

References

1.
Global Tuberculosis Report 2019: WHO Report. World Health Organization; 2019.
2.
World Health Organisation. The End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after. 2015.
3.
Butov D, Kuzhko M, Makeeva N, Butova T, Stepanenko H, Dudnyk A. Association of interleukins genes polymorphisms with multi-drug resistant tuberculosis in Ukrainian population. Pneumonol Alergol Pol. 2016. p. 168–73.
4.
Dudnyk A, Butov D, Crudu V, Lange C, Chesov D. MDR-TB in Eastern Europe in the era of the TB elimination action framework. Int J Tuberc Lung Dis. 2017. p. 2–3.
5.
Cox H, Kebede Y, Allamuratova S, Ismailov G, Davletmuratova Z, Byrnes G, et al. Tuberculosis recurrence and mortality after successful treatment: Impact of drug resistance. PLoS Med. 2006. p. 384.
6.
Gelmsnova I, Khan A, Becerra F, Zemlyanaya M, Unakova N, Andreev I, et al. Low rates of recurrence after successful treatment of multidrugresistant tuberculosis in Tomsk, Russia. Int J Tuberc Lung Dis. 2015. p. 399–405.
7.
Chin A, Rylance J, Makumbirofa S, Meffert S, Vu T, Clayton J, et al. Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study. Int J Tuberc Lung Dis. 2019. p. 203–11.
8.
Butov D, Gumenuik M, Gumeniuk G, Tkachenko A, Kikinchuk V, Stepaniuk R, et al. Effectiveness of anti-tuberculosis chemotherapy in patients with tuberculosis relapse compared with newly diagnosed patients. Int J Mycobacteriol. 2019. p. 341–6.
9.
Tuberculosis prevention, care and control: a practical directory of new advances. World Health Organisation; 1AD.
10.
Xpert MTB/RIF implementation manual: technical and operational ’howto. World Health Organisation; 1AD.
11.
World Health Organisation. Definitions and reporting framework for tuberculosis -2013 revision. 1AD.
12.
Stinson K, Eisenach K, Matsumoto M, Siddiqi S, Nakashima S, Hashizume H, et al. Mycobacteriology Laboratory Manual. WHO; 2014.
13.
Lapach S, Chubenko A, Babich P. Statistical methods in biomedical studies using excel. Morion; 2000.
14.
Berkani M, Chaulet P, Darbyshire J, Nunn A, Fox W. Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the algerian sahara. Final report: results 3 years after the onset of treatment. Rev Mal Respir. 1986. p. 73–5.
15.
World Health Organisation consolidated guidelines on drug-resistant tuberculosis treatment. 30AD.
16.
Mirsaeidi M, Sadikot R. Patients at high risk of tuberculosis recurrence. Int J Mycobacteriol. 2018. p. 1–6.
17.
Chang K, Leung C, Yew W, Ho S, Tam C. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004. p. 1124–30.
18.
Qin F, Barry P, Pascopella L. Factors associated with extended treatment among tuberculosis patients at risk of relapse in California. Int J Tuberc Lung Dis. 2016. p. 363–9.
19.
Rogozhina N, Gur’ianov, Vn, Babin M. The social-clinical aspects of recurrences of pulmonary tuberculosis. Probl Tuberk. 1993. p. 54–5.
20.
Butov D, Feshchenko Y, Kuzhko M, Gumenuik M, Yurko K, Grygorova A, et al. Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection. Tuberc Respir Dis. 2020. p. 96–9.
21.
Feshchenko Y, Butov D, Kuzhko M, Gumeniuk M, Butova T. Efficacy and safety of intravenous chemotherapy during intensive treatment phase in patients with newly diagnosed pulmonary tuberculosis. Adv Respir Med. 2018. p. 159–67.
22.
Kissina T, Freidlin I, Knoring B, Basek T. Elkin AB. Features of specific immune response in the patients with fibrous/cavernous tuberculosis of lungs. Med Immunol. 2006. p. 501–10.
23.
Krasnov V, Potashova V, Zyrianova T. Naryshkina SL. Clinical aspects and outcome of recurrent pulmonary tuberculosis. Probl Tuberk. 1993. p. 14–6.
24.
Riekstinia V, Torp L, Leĭmane V. Risk factors for early relapse of tuberculosis in Latvia. Probl Tuberk Bolezn Legk. 2005. p. 43–7.
25.
Zakoska M. Risk factors for relapses of tuberculosis. Eur Resp J. 2003. p. 2172–9.
26.
Datiko D, Lindtjørn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in Southern Ethiopia: retrospective cohort study. BMC Public Health; 2009. p. 348.

Citation

Copyright

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

{{ submission.title }}
Issue image
Vol 17, Issue 2, 2020
Pectoralis (PecS) nerve block 1 for port-a-cath removal and central venous catheter (CVC) replacement Interdisciplinary aspects of possible negative effects of dogs on humans in Bosnia and Herzegovina Securing the base of the appendix during laparoscopic appendectomy Epidemiology of injuries connected with dance: a critical review on epidemiology Spatio-temporal data visualization for monitoring of control measures in the prevention of the spread of COVID-19 in Bosnia and Herzegovina See full issue

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.